FDA Warning Letter — Beijing Xinggu Lvsan Technology Co., Ltd

Case 633904 — FEI 3017227582

The FDA took a Warning Letter action against Beijing Xinggu Lvsan Technology Co., Ltd on October 5, 2022 (Beijing, China). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.

Action Details

Facility
Beijing Xinggu Lvsan Technology Co., Ltd
Date
October 5, 2022
Fiscal Year
2023
Product Type
Drugs
Center
CDER
Location
Beijing (China)